Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk‐stratify patients for alloimmunisation risk-Reference-Cited by-同舟云学术

Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk‐stratify patients for alloimmunisation risk

Published:2020-05-20 Issue:4 Volume:30 Page:263-274
ISSN:0958-7578
Container-title:Transfusion Medicine
language:en
Short-container-title:Transfusion Med

Author:

Shih Andrew W.¹^ORCID,Yan Matthew T.S.¹²,Elahie Allahna L.³⁴,Barty Rebecca L.⁴⁵,Liu Yang⁴⁵,Berardi Philip⁶⁷,Azzam Mona⁸,Siddiqui Reda⁴,Parvizian Michael K.⁴⁵,Mcdougall Tara⁴,Heddle Nancy M.³⁴⁹,Al‐Habsi Khalid S.¹⁰,Goldman Mindy⁶⁷,Cote Jacqueline¹¹,Athale Uma¹²,Verhovsek Madeleine M.³⁴⁵¹³

Affiliation:

1. Department of Pathology and Laboratory MedicineUniversity of British Columbia Vancouver British Columbia Canada

2. Medical Services and Hospital RelationsCanadian Blood Services Vancouver British Columbia Canada

3. Hamilton Regional Laboratory Medicine ProgramMcMaster University Hamilton Ontario Canada

4. Department of MedicineMcMaster University Hamilton Ontario Canada

5. McMaster Centre for Transfusion ResearchMcMaster University Hamilton Ontario Canada

6. Department of Pathology and Laboratory MedicineUniversity of Ottawa Ottawa Ontario Canada

7. Centre for InnovationCanadian Blood Services Ottawa Ontario Canada

8. Department of PediatricsSuez Canal University Ismailia Egypt

9. Centre for InnovationCanadian Blood Services Hamilton Ontario Canada

10. Department of Blood Banks ServicesDirectorate General of Specialized Medical Care, Ministry of Health Muscat Oman

11. National Immunohematology Reference LaboratoryCanadian Blood Services Ottawa Ontario Canada

12. Department of PediatricsMcMaster University Hamilton Ontario Canada

13. Department of Pathology and Molecular MedicineMcMaster University Hamilton Ontario Canada

Funder

McMaster Department of Pathology and Molecular Medicine

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tme.12685

Reference38 articles.

1. Developing a Global Agenda for Sickle Cell Disease

2. An Evidence-Based Approach to the Treatment of Adults with Sickle Cell Disease

3. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management

4. Severe reactions associated with transfusion of patients with sickle cell disease

5. Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature;Immunohematology;2024-06-01

2. Transfusing children with sickle cell disease using blood group genotyping when the pool of Black donors is limited;Transfusion;2024-03-18

3. RHCE and Kell genotyping and alloimmunization profile in patients with sickle cell disease in the Federal District of Brazil;Hematology, Transfusion and Cell Therapy;2023-06

4. Genotyping and the Future of Transfusion in Sickle Cell Disease;Hematology/Oncology Clinics of North America;2022-12